ACIM
EW icon

Azimuth Capital Investment Management’s Edwards Lifesciences EW Stock Holding History

Azimuth Capital Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Sell
201,325
-22,092
-10% -$1.85M 0.61% 48
2026
Q1 		$17.9M Buy
223,417
+108,264
+94% +$8.93M 0.67% 36
2025
Q4 		$9.82M Buy
+115,153
New +$9.45M 0.35% 101
2023
Q4 		– Sell
-90,483
Closed -$6.27M – 304
2023
Q3 		$6.27M Sell
90,483
-2,099
-2% -$169K 0.31% 116
2023
Q2 		$8.73M Sell
92,582
-1,693
-2% -$147K 0.42% 77
2023
Q1 		$7.8M Sell
94,275
-2,809
-3% -$221K 0.38% 95
2022
Q4 		$7.24M Sell
97,084
-3,559
-4% -$274K 0.37% 98
2022
Q3 		$8.32M Sell
100,643
-793
-0.8% -$76.3K 0.45% 70
2022
Q2 		$9.65M Buy
+101,436
New +$10.5M 0.49% 67

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Azimuth Capital Investment Management's EW Position: Q2 2026 in Review

Azimuth Capital Investment Management reduced its Edwards Lifesciences (EW) stake by 9.9% in Q2 2026, selling an estimated $1.85M and leaving 201,325 shares worth $18.2M. The position accounts for 0.61% of the portfolio, ranked #48.

Azimuth Capital Investment Management first reported a position in EW in Q2 2022 and has held it in 9 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Azimuth Capital Investment Management held 201,325 shares of Edwards Lifesciences worth $18.2M as of Q2 2026.
  • Azimuth Capital Investment Management sold 22,092 Edwards Lifesciences shares in Q2 2026, an estimated $1.85M.
  • Edwards Lifesciences made up 0.61% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #48 holding.
  • Azimuth Capital Investment Management first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 9 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.